The U.S. Food and Drug Administration (FDA) has granted an emergency use authorization for Moderna’s and Pfizer-BioNTech’s updated booster vaccines, which target the BA.4/BA.5 coronavirus subvariants. www.science.org/content/article/omicron-booster-shots-are-coming-lots-questions? For the first time since the start of the pandemic, COVID-19 vaccines look...

Article by Lalita Panicker, Consulting Editor, Views and Editor, Insight, Hindustan Times, New Delhi Advisers to the US Centers for Disease Control and Prevention (CDC) has voted in favour of the Bavarian Nordic's Jynneos vaccine for all adults at risk...